MNS Closes Oversubscribed Financing to Advance MiracusTM Needle-Free Patch Platform into First-in-Human TrialsBeckie Barrett2026-01-23T16:01:07+00:00January 26th, 2026|News|
How Start-ups and Investors Can Accelerate Sustainable ChemistryBeckie Barrett2026-01-12T13:06:37+00:00January 12th, 2026|Article, Wilton Centre|
AAVantgarde Closes $141m Series B Round to Tackle Inherited Eye DiseasesBeckie Barrett2025-11-27T16:31:14+00:00November 27th, 2025|Investment, News|
Victoria House Celebrates London Life Sciences WeekBeckie Barrett2025-11-26T16:53:07+00:00November 26th, 2025|News|
The Rise of Shared Lab Space: How Kent Science Park is Leading the ChargeBeckie Barrett2025-11-06T16:46:53+00:00November 6th, 2025|Article, Kent Science Park|
Why Life Sciences Startups are Flocking to Central LondonBeckie Barrett2025-10-28T07:57:44+00:00October 27th, 2025|Article|
OxCam Growth Corridor: A Golden OpportunityBeckie Barrett2025-10-17T13:57:33+01:00October 22nd, 2025|Article, Colworth Park|
Victoria House Premieres a New Era for UK Life Sciences Beckie Barrett2025-10-27T14:47:17+00:00October 20th, 2025|Article|
The Art of Science: Stories of Discovery from the Victoria House Launch Beckie Barrett2025-10-20T15:06:33+01:00October 20th, 2025|Article, London | Victoria House|
New Accelerator Programme to Drive Breakthroughs in Managing Chronic ConditionsBeckie Barrett2025-09-03T11:49:38+01:00September 3rd, 2025|Accelerator, Article, News|
